Momentum Public Relations
Press Release: October 16, 2017
October 16, 2017 / TheNewswire / MONTREAL, QUEBEC, Momentum PR client, Relevium Technologies., is listed on the TSX Venture Exchange under the symbol: RLV and in Germany on the FSE under the symbol: 6BX.
Momentum PR is pleased to have produced an informative and comprehensive report on Relevium Technologies, available on the Momentum PR website.
Relevium Business Model:
– Montreal-based Relevium Technologies has embarked on an aggressive acquisition plan to become a Canadian brand name in the booming e-commerce health and wellness sector; concentrating on the nutraceutical and cosmeceutical markets.
–Goldstein Research predicts US$300 Billion Nutraceutical Market By 2024
Creating new Brands
-Building new brands for fitness and pet nutraceuticals
-During the first 50 days BioGanix sales reached $CAD 700,000. BioGanix is operating under Relevium’s US subsidiary BGX E-Health.
–Relevium hired agileDSS as a data architect to start work on the company’s big data and AI Product Trend-Recognition Engine.
-The company believes that if it is successful, the Product Trend-Recognition Engine would allow it to launch the right products in the right market, long before any competitor.
-HempCo sells hemp protein powder, hemp oil and hulled hemp seed nut, under its brand PlanetHemp on a B2B (business-to-business) basis.
-The agreement calls for the joint development of a complete line of hemp-based nutraceutical and nutritional products, for distribution through global e-commerce platforms including Amazon and Jet.com. Relevium will also develop B2C (business-to-consumer).
Research house MarketsandMarkets has predicted that the global wellness supplement market will hit US$249.4 Billion during 2020, up from US$183.1 Billion in 2015.
Relevium Technologies CEO Aurelio Useche describes the sectors like this: “Both nutraceuticals and cosmeceuticals come from the combination of nature and science. They are a combination of natural ingredients with some science behind them.”
The market is being driven by a variety of factors, ranging from increased knowledge about the benefits supplements can provide, to aging boomers wanting to live better longer. Another driver is the increasing belief that natural ingredients are better than synthetic compounds, with far fewer side effects.
Relevium is also in advanced discussions with other e-commerce companies and is targeting the execution of a second acquisition of either a nutraceutical or cosmeceutical company by the end of the year.
“I see the company becoming a portfolio of health and wellness brands that have become well-recognized in the marketplace. In terms of size, we aim for a company with C$500 Million in annual revenues and the ability to offer our investors dividends,” said CEO Aurelio Useche.
Relevium trades on the TSXV as RLV and on the FSE as 6BX. As of October 11, 2017 it closed at C$0.12 and has a 52-week high of C$0.22 and a low of C$0.045. The company has 66,971,466 shares outstanding and a market cap of C$7.9 million.
The Momentum PR informative and comprehensive report on Relevium Technologies is available on the Momentum PR website.
If you would like more information on Relevium; listed on the TSX Venture Exchange under the symbol RLV or would like to arrange an interview with management please contact:
Juliette Benard, Director Media Relations
About Momentum PR
Momentum PR is a cutting-edge public and investor relations consulting agency representing companies within the Canadian investment community.
Since 2009, Momentum PR has been servicing small and mid-cap Canadian listed public companies, seeking to increase their exposure across North America. The focus at Momentum PR is on building and driving brand awareness. Momentum PR cultivates new audiences in the media and investment communities by proactively engaging interested parties on behalf of client companies through online and offline channels.
Read it on The Newswire